Scale-up Systems and ScienView Team Up on Process Development
News May 14, 2013
Scale-up Systems Ltd. announced it has entered into a multi-year agreement with ScienView Co. Ltd. to provide DynoChem® software, training and process development support services to the Chinese pharmaceutical industry.
The motivation behind the agreement is to provide a dedicated local presence to help Chinese users to obtain maximum value from DynoChem’s tools. The initial team in the Beijing and Shanghai offices will be led by Dr. Jinjun Wang for Training & Technical Support and Jack Ma on the Business side.
According to Scale-up Systems CEO Dr. Joe Hannon, “We have been looking for a partner in China that, like our company, specialises in working with and understands the needs of the pharma and life sciences industry. We are therefore delighted to be working with ScienView.”
Scale-up Systems COO Dr. Steve Hearn said “What made ScienView stand out to us was the value it placed on hiring high quality training and support staff across multiple domains.”
ScienView’s Vice President of Informatics Services, Dr. Zhen Wang stated, “Many of our clients are pharmaceutical, chemical or CRO companies, and they are delighted to know that DynoChem will be provided to them along with our top-quality support. With the rapidly increasing R&D investments in China, businesses here also face significant challenges on managing costs and reducing pollution. DynoChem is an excellent tool to help them achieve these goals and is complementary to our products and services.”
Jack Ma, Business Development Manager for ScienView, added that “as the founder of the Shanghai Scientific Informatics Salon, a technical networking forum for big pharma, CRO and chemical companies as well as academics, ScienView finds that scientists and engineers here are very interested in new techniques and tools that can be applied successfully to their work and can be effectively supported by a local team.”
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
U.S. Study of Dapivirine Ring in Lactating Women Finds Little Drug Gets Into Breast MilkNews
The antiretroviral drug dapivirine that is released from an experimental vaginal ring to protect against HIV is absorbed in very low concentrations into breastmilk.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018